Cargando…
Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12
Dysregulated expression of splicing factors has important roles in cancer development and progression. However, it remains a challenge to identify the cancer-specific splicing variants. Here we demonstrate that spliceosome component BUD31 is increased in ovarian cancer, and its higher expression pre...
Autores principales: | Wang, Zixiang, Wang, Shourong, Qin, Junchao, Zhang, Xiyu, Lu, Gang, Liu, Hongbin, Guo, Haiyang, Wu, Ligang, Shender, Victoria O., Shao, Changshun, Kong, Beihua, Liu, Zhaojian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587234/ https://www.ncbi.nlm.nih.gov/pubmed/36271053 http://dx.doi.org/10.1038/s41467-022-34042-w |
Ejemplares similares
-
Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2
por: Wang, Shourong, et al.
Publicado: (2021) -
SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52
por: Diao, Yuchao, et al.
Publicado: (2022) -
MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2
por: Tian, Xiaoxue, et al.
Publicado: (2020) -
The splicing factor SF3B4 drives proliferation and invasion in cervical cancer by regulating SPAG5
por: Li, Yingwei, et al.
Publicado: (2022) -
Mitochondrial superoxide contributes to oxidative stress exacerbated by DNA damage response in RAD51-depleted ovarian cancer cells
por: Xu, Limei, et al.
Publicado: (2020)